<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Radiofrequency ablation (RFA) is a common procedure for the management of colorectal <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>RFA-generated lesions are surrounded by a rim of <z:mp ids='MP_0005039'>hypoxia</z:mp> that is associated with aggressive outgrowth of intrahepatic micrometastases </plain></SENT>
<SENT sid="2" pm="."><plain><z:mp ids='MP_0005039'>Hypoxia</z:mp>-activated <z:chebi fb="0" ids="50266">prodrugs</z:chebi> such as tirapazamine are designed selectively to induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells under hypoxic conditions </plain></SENT>
<SENT sid="3" pm="."><plain>Therefore, it was hypothesized that tirapazamine may have therapeutic value in limiting <z:mp ids='MP_0005039'>hypoxia</z:mp>-associated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> outgrowth following RFA </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Murine C26 and MC38 <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells were grown under <z:mp ids='MP_0005039'>hypoxia</z:mp> and <z:mpath ids='MPATH_458'>normal</z:mpath> oxygenation in vitro, and treated with different concentrations of tirapazamine </plain></SENT>
<SENT sid="5" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> and cell cycle distribution were assessed by western blot and fluorescence-activated cell sorting analysis </plain></SENT>
<SENT sid="6" pm="."><plain>Proliferative capacity was tested by means of colony-formation assays </plain></SENT>
<SENT sid="7" pm="."><plain>Mice harbouring microscopic colorectal <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> were treated with RFA, followed by a single injection of tirapazamine (60 mg/kg) or saline </plain></SENT>
<SENT sid="8" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumour</z:e> load was assessed morphometrically 7 days later </plain></SENT>
<SENT sid="9" pm="."><plain>RESULTS: Tirapazamine induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumour</z:e> cells under <z:mp ids='MP_0005039'>hypoxia</z:mp> in vitro </plain></SENT>
<SENT sid="10" pm="."><plain>Under <z:mpath ids='MPATH_458'>normal</z:mpath> oxygenation, tirapazamine caused a G2 cell cycle arrest from which cells recovered partly </plain></SENT>
<SENT sid="11" pm="."><plain>This reduced, but did not abolish, colony-forming capacity </plain></SENT>
<SENT sid="12" pm="."><plain>A single dose of tirapazamine largely prevented accelerated outgrowth of hypoxic micrometastases following RFA </plain></SENT>
<SENT sid="13" pm="."><plain>Tirapazamine administration was associated with minimal toxicity </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSION: Tirapazamine induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells in a <z:mp ids='MP_0005039'>hypoxia</z:mp>-dependent manner and potently suppressed <z:mp ids='MP_0005039'>hypoxia</z:mp>-associated outgrowth of <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> with limited toxicity </plain></SENT>
<SENT sid="15" pm="."><plain>This warrants further study to assess the potential value of tirapazamine, or other <z:mp ids='MP_0005039'>hypoxia</z:mp>-activated <z:chebi fb="0" ids="50266">prodrugs</z:chebi>, as adjuvant therapeutics following RFA treatment of colorectal <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> </plain></SENT>
</text></document>